Cargando…
Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
OBJECTIVE: To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime plus metronidazole (C + M) for preventing surgical site infections (SSI) in colorectal surgery. BACKGROUND: Given their spectra that include most Enterobacterales and anaerobes, C + M is commonly recommended a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510121/ https://www.ncbi.nlm.nih.gov/pubmed/37726838 http://dx.doi.org/10.1186/s13756-023-01307-y |
_version_ | 1785107897116524544 |
---|---|
author | Stavropoulou, Elisavet Atkinson, Andrew Eisenring, Marie-Christine Fux, Christoph A. Marschall, Jonas Senn, Laurence Troillet, Nicolas |
author_facet | Stavropoulou, Elisavet Atkinson, Andrew Eisenring, Marie-Christine Fux, Christoph A. Marschall, Jonas Senn, Laurence Troillet, Nicolas |
author_sort | Stavropoulou, Elisavet |
collection | PubMed |
description | OBJECTIVE: To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime plus metronidazole (C + M) for preventing surgical site infections (SSI) in colorectal surgery. BACKGROUND: Given their spectra that include most Enterobacterales and anaerobes, C + M is commonly recommended as prophylaxis of SSI in colorectal surgery. A/CA offers good coverage of Enterobacterales and anaerobes as well, but, in contrast to C + M, it also includes Enterococcus faecalis which is also isolated from patients with SSI and could trigger anastomotic leakage. METHODS: Data from a Swiss SSI surveillance program were used to compare SSI rates after class II (clean contaminated) colorectal surgery between patients who received C + M and those who received A/CA. We employed multivariable logistic regression to adjust for potential confounders, along with propensity score matching to adjust for group imbalance. RESULTS: From 2009 to 2018, 27,922 patients from 127 hospitals were included. SSI was diagnosed in 3132 (11.2%): 278/1835 (15.1%) in those who received A/CA and 2854/26,087 (10.9%) in those who received C + M (p < 0.001). The crude OR for SSI in the A/CA group as compared to C + M was 1.45 [CI 95% 1.21–1.75]. The adjusted OR was 1.49 [1.24–1.78]. This finding persisted in a 1:1 propensity score matched cohort of 1835 patients pairs with an OR of 1.60 [1.28–2.00]. Other factors independently associated with SSI were an ASA score > 2, a longer duration of operation, and a reoperation for a non-infectious complication. Protective factors were female sex, older age, antibiotic prophylaxis received 60 to 30 min before surgery, elective operation, and endoscopic approach. CONCLUSIONS: Despite its activity against enterococci, A/CA was less effective than C + M for preventing SSI, suggesting that it should not be a first choice antibiotic prophylaxis for colorectal surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-023-01307-y. |
format | Online Article Text |
id | pubmed-10510121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105101212023-09-21 Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery Stavropoulou, Elisavet Atkinson, Andrew Eisenring, Marie-Christine Fux, Christoph A. Marschall, Jonas Senn, Laurence Troillet, Nicolas Antimicrob Resist Infect Control Research OBJECTIVE: To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime plus metronidazole (C + M) for preventing surgical site infections (SSI) in colorectal surgery. BACKGROUND: Given their spectra that include most Enterobacterales and anaerobes, C + M is commonly recommended as prophylaxis of SSI in colorectal surgery. A/CA offers good coverage of Enterobacterales and anaerobes as well, but, in contrast to C + M, it also includes Enterococcus faecalis which is also isolated from patients with SSI and could trigger anastomotic leakage. METHODS: Data from a Swiss SSI surveillance program were used to compare SSI rates after class II (clean contaminated) colorectal surgery between patients who received C + M and those who received A/CA. We employed multivariable logistic regression to adjust for potential confounders, along with propensity score matching to adjust for group imbalance. RESULTS: From 2009 to 2018, 27,922 patients from 127 hospitals were included. SSI was diagnosed in 3132 (11.2%): 278/1835 (15.1%) in those who received A/CA and 2854/26,087 (10.9%) in those who received C + M (p < 0.001). The crude OR for SSI in the A/CA group as compared to C + M was 1.45 [CI 95% 1.21–1.75]. The adjusted OR was 1.49 [1.24–1.78]. This finding persisted in a 1:1 propensity score matched cohort of 1835 patients pairs with an OR of 1.60 [1.28–2.00]. Other factors independently associated with SSI were an ASA score > 2, a longer duration of operation, and a reoperation for a non-infectious complication. Protective factors were female sex, older age, antibiotic prophylaxis received 60 to 30 min before surgery, elective operation, and endoscopic approach. CONCLUSIONS: Despite its activity against enterococci, A/CA was less effective than C + M for preventing SSI, suggesting that it should not be a first choice antibiotic prophylaxis for colorectal surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-023-01307-y. BioMed Central 2023-09-19 /pmc/articles/PMC10510121/ /pubmed/37726838 http://dx.doi.org/10.1186/s13756-023-01307-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Stavropoulou, Elisavet Atkinson, Andrew Eisenring, Marie-Christine Fux, Christoph A. Marschall, Jonas Senn, Laurence Troillet, Nicolas Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery |
title | Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery |
title_full | Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery |
title_fullStr | Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery |
title_full_unstemmed | Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery |
title_short | Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery |
title_sort | association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510121/ https://www.ncbi.nlm.nih.gov/pubmed/37726838 http://dx.doi.org/10.1186/s13756-023-01307-y |
work_keys_str_mv | AT stavropoulouelisavet associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery AT atkinsonandrew associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery AT eisenringmariechristine associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery AT fuxchristopha associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery AT marschalljonas associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery AT sennlaurence associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery AT troilletnicolas associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery |